Panavir, gel, 30g

Composition

Active ingredient:

panavir® (polysaccharides of Solanum tuberosum shoots) 0.002 g;

Auxiliary substances:

glycerol

-30 g; macrogol

4000-15 g;

macrogol 400-38 g; ethanol 95% – 1 g;

sodium hydroxide-0.4 g;

lanthanum nitrate hexahydrate-2.2 g;

water-up to 100 g;

Pharmacological action

Panavir® is a purified extract of Solanum tuberosum plant shoots; the main Active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, and uronic acids.

Panavir ® is an antiviral and immunomodulatory agent. Increases the body’s non-specific resistance to various infections and promotes the induction of interferons alpha and gamma by blood leukocytes.

In therapeutic doses, the drug is well tolerated.

Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies on laboratory animals, a negative effect on the reproductive function and development of the fetus was not established.

It has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation and in the test of pseudoallergic inflammatory response to concanavalin A.

Analgesic effect was shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation.

It has an antipyretic effect.

Neuroprotective properties are shown on the model of Parkinsonian syndrome caused by systemic use of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

It has the ability to improve the function of the retina and optic nerve.

It has wound-healing properties in the model of gastric ulcer.

Indications

Infectious and inflammatory diseases of the skin and / or mucous membranes caused by the herpes simplex virus Herpes simplex types I and II, including genital herpes.

Use during pregnancy and lactation

Use during pregnancy is only possible if the intended benefit to the mother outweighs the potential risk to the fetus.

If it is necessary to use the drug during lactation, breastfeeding should be discontinued for the duration of the drug.

Contraindications

• individual intolerance and hypersensitivity to the components of the drug;
• children under 18 years of age.

Side effects

There may be rapid redness and itching of the skin and / or mucous membranes at the site of application of the gel.

How to take, course of use and dosage

Externally and topically. The gel is applied in a thin layer to the affected areas of the skin and/or mucous membranes 5 times a day.

The duration of treatment is 4-5 days.

The course of treatment can be extended up to 10 days.

Special instructions

it is recommended to start treatment at the earliest possible stage of the disease, at the first signs (itching, tingling, redness, feeling of tension), in this case, the development of the vesicular stage of the disease can be completely prevented.

Panavir ® gel is not intended for use in ophthalmology. When applying the gel on the face, avoid contact with the eyes.

Product form

gel for local application

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

3 years

Active ingredient

Extract of potato shootsra.

Dosage form

gel for external use

Description

For adults as directed by your doctor

Indications

Herpes